Clinical trials
Phase 3 Prostatic Hyperplasia trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 3 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 5 |
| 2010 | 2 |
| 2011 | 2 |
| 2013 | 2 |
| 2019 | 2 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 5 |
| Nymox Corporation | 4 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 3 |
| Watson Pharmaceuticals | 3 |
| AEterna Zentaris | 2 |
| Sanofi | 2 |
| Urovant Sciences GmbH | 2 |
| GlaxoSmithKline | 1 |
| Health Ever Bio-Tech Co., Ltd. | 1 |
| Sophiris Bio Corp | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Hyperplasia | 25 |
| Lower Urinary Tract Symptoms | 4 |
| Urinary Bladder Neck Obstruction | 2 |
| Urinary Bladder, Overactive | 2 |
| Erectile Dysfunction | 1 |
| Genital Diseases, Male | 1 |
| Hyperplasia | 1 |
| Prostatic Diseases | 1 |
| Signs and Symptoms | 1 |
| Urinary Retention | 1 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.